Article
NF-κB as a therapeutic target in chronic lymphocytic leukemia
12 Feb 2010
Abstract excerpt
IMPORTANCE OF THE FIELD: NF-kappaB includes a family of transcription factors that play a critical role in the biology of normal lymphocytes and it is aberrantly activated in chronic lymphocytic leukemia (CLL) cells. Here, we review the role of constitutive NF-kappaB activation in CLL pathogenesis and its potential as a therapeutic target for CLL treatment. AREAS COVERED IN THIS REVIEW: This review highlights the...
